ReviewFrontiers in pharmacology2025

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development.

Nuria Gómez-Cebrián et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.